Rhythm Pharmaceuticals, Inc. (RYTM)
97.35
+0.74
(+0.77%)
USD |
NASDAQ |
May 07, 09:41
Rhythm Pharmaceuticals SG&A Expense (TTM) : 155.85M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Aldeyra Therapeutics, Inc. | 9.602M |
| Eli Lilly & Co. | 11.56B |
| Merck & Co., Inc. | 10.88B |
| Sarepta Therapeutics, Inc. | 491.72M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |